- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Pseudobulbar Affect (PBA) In Geriatric & Long-Term Care Patients
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Pseudobulbar Affect (PBA) In Geriatric & Long-Term Care Patients
PBA is a neurologic condition that occurs secondary to a variety of otherwise unrelated neurologic conditions and is characterized by sudden, frequent, uncontrollable episodes of laughing and/or crying.1,2 Residents in long-term care settings with PBA symptoms may have different characteristics with their medication usage or behavioral symptoms compared to those residents without PBA symptoms.3,4 In this webinar, our panelists will be reviewing PBA characteristics, neurocircuitry and pathophysiology, PBA prevalence, the impact of PBA on patients and assessment of PBA symptoms.
References:-
1. Cummings JL, et al. CNS Spectr. 2006;11(6):1-7
2. Wortzel HS, et al. CNS Drugs. 2008; 22(7):531-545
3. Foley K et al. Int J Geriatr Psychiatry. 2016;31:694-701
4. Zarowitz BJ, et al. Consultant Pharm. 2013;28:713-22Featuring
Justin Rash, PharmD, BCGP (OPDC)
Senior Medical Science Liaison
Michelle Lavagnino, DrPH(c) (OPDC)
Medical Science Liaison, Long-term Care
Justin Rash and Michelle Lavagnino are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
-
The Danger of Post-Traumatic Stress Disorder (PTSD) Stigma Among Marginalized Communities
October 10 12:00 pm to 1:00 pm
Registration
Related Resources
-
2024 Mental Health America (MHA) Mental Health Month Toolkit
Downloadable Resource May 1, 2024In celebrating May Mental Health Month, MHA released their highly anticipated 2024 Mental Health Month toolkit! This year the toolkit theme is Where to Start: Mental Health in a Changing World. The…
-
Understanding Digital Therapeutics
Infographic April 22, 2024Digital therapeutics (DTx) deliver software-based interventions to patients to treat, manage, or prevent a disease or condition.
-
Understanding MDD Treatments With Neuroplastic Effects
Infographic April 22, 2024Researchers are exploring whether it is possible to leverage neuroplasticity to develop treatments for depression.
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: